ALIN
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97005028
- Registration number
- 7498122
- Mark type
- Stylized text
- Filed
- 31 Aug 2021
- Published for opposition
- 25 Jun 2024
- Registered
- 10 Sept 2024
- Attorney of record
- Jennifer A. Van Kirk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis, scleritis, uveitis, iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival, corneal physical, chemical burning, and inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea and vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
Owner
- Productos Farmaceuticos S.A. de C.V., Ciudad de México, MX
- Productos Farmaceuticos S.A. de C.V., Ciudad de México, MX
- Productos Farmaceuticos S.A. de C.V., Ciudad de México, MX
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Apr 2024 — ASSIGNED TO LIE
- 11 Dec 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 29 Nov 2023 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 29 Nov 2023 — INQUIRY TO SUSPENSION E-MAILED
- 29 Nov 2023 — SUSPENSION INQUIRY WRITTEN
- 01 Jun 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 01 Jun 2023 — LETTER OF SUSPENSION E-MAILED